At the BioBusiness2024 program (25-29 November 2024), Dr. Passant Atallah (Leibniz-Institute, Dresden) won the BioBusiness 2024 award. She presented the business case for ResCure Dressing, an innovative wound dressing aimed at healing inflammatory skin diseases
We warmly welcome Dr. Melanie Wiesel as a new member of the CASE BioMed advisory board. Dr. Melanie Wiesel is Head of Operations at Wyss Zurich Translational Center, a unique accelerator embedded within ETHZ & UZH.
During the BioBusiness2024 program we warmly welcomed new faculty members: Dr. Angelina Rau, BSc., MLaw, Ph.D. in Biomedical Law & Ethics works as a lawyer at VISCHER and Dr. Alexander Ehlgen who is an Investment Manager at the Boehringer Ingelheim Venture Fund
Co-founded by Dr. T. Fessard, BioBusiness2010 alumnus, SpiroChem is a research partner driving innovation across the drug discovery and process R&D chemistry value chains. Headquartered in Basel, it has presence in proximity to life science hubs, including a new site in Canada.
Dr. Bogdan Mateescu, UZH, Brain Research Institute The program was such a transformative experience. It wasn’t just the top-profile teachers, but also the cohort of participants who were both incredibly smart and embodied a genuine entrepreneurial spirit.
